Ovarian Hormone Replacement. Maria Wolfs MD MHSc FRCPC Assistant Professor University of Toronto Endocrinology St. Michael s Hospital
|
|
- Hector Houston
- 6 years ago
- Views:
Transcription
1 Ovarian Hormone Replacement Maria Wolfs MD MHSc FRCPC Assistant Professor University of Toronto Endocrinology St. Michael s Hospital
2 Disclosures None to declare
3 Outline Hormones and the Menstrual cycle Ovarian hormone replacement Estrogens Progesterone Indications for replacement Cases
4 Outline Hormones and the Menstrual cycle Ovarian hormone replacement Estrogens Progesterone Indications for replacement Cases
5 Menstrual cycle
6 Follicular phase estrogen endometrial proliferation cervical mucous Follicular phase Luteal phase Ovulation Luteal phase progesterone endometrial maturation cervical mucous Menses
7 Cervical mucous changes Follicular phase Luteal phase Basal Body Temperature
8 Insulin LH Estrogen production Cholesterol Pregnenolone THECA CELL Progesterone GRANULOSA CELL FSH 17-OH Progesterone Androstenedione Aromatase Estrone Estradiol Testosterone
9 Estrogen crucial for the development of the antrum and maturation of the Graafian follicle actions of estradiol induction of FSH receptors on granulosa cells, proliferation and secretion of follicular thecal cells, induction of LH receptors on granulosa cells proliferation of endometrial stromal and epithelial cells E type cervical mucous
10 Estrogen feedback on LH and FSH Negative feedback At low circulating levels Positive feedback At very high levels Positive feedback loop on itself Estrogen induced proliferation of estrogen-converting granulosa cells and synthesis of estrogen receptors
11
12 Serum Estradiol Levels Estradiol (pmol/l) P-4 P-2 P P+2 P+3 P+5 P+7 P+9 P+11 Cycle day
13
14 Progesterone secreted by luteinized follicles requires p450 enzyme two circulating forms Progesterone 17-hydroxy-progesterone
15 Progesterone stimulate the release of proteolytic enzymes from thecal cells prepare for ovulation induce migration of blood vessels into the follicle wall stimulate prostaglandin secretion in follicular tissues induce swelling and increased secretion of the endometrium
16 Serum Progesterone Levels Serum Progesterone nmol/l P+3 P+5 P+7 P+9 P+11 Cycle day
17 Hormone levels 450 pmol/l 50 nmol/l
18 Outline Hormones and the Menstrual cycle Ovarian hormone replacement Estrogens Progesterone Indications for replacement Cases
19 Bioavailable hormone replacement The Endocrine Society Position Statement there is little or no evidence to support the claim that bioidentical hormones are safer or more effective than the commonly used synthetic versions of hormone replacement therapy (HRT) US Food and Drug Administration has ordered pharmacies to stop providing estriol, stating that it is a new, unapproved drug with unknown safety and effectiveness Endocrine Society. Bioidentical Hormones Position Statement, October
20 Bioavailable hormone replacement Bioidentical hormones chemical structure identical to human hormones chemically synthesized, such as progesterone, estriol, and estradiol Non-bioidentical hormones not structurally identical to human hormones chemically synthesized (MPA) derived from a nonhuman source (CEE)
21 Estradiol 17-B estradiol Ethynyl estradiol Conjugated equine estrogen Risk/benefits
22 Estrogen the fountain of youth?
23 Estradiol Transdermal patch Oral Vaginal
24 Oral estradiol Estrace Cost 0.5 mg $ mg $ mg $ tablets
25 Estrogel estradiol-17β hemihydrate Two metered-actuations = 2.5 g of gel (1.5 mg E2) Application instructions apply ESTROGEL to both arms alternate sites of application are the abdomen or the inner thighs must not be applied to the breasts, the face or to irritated or damaged skin allow the gel to dry approximately 2 minutes before covering with clothing
26 Transdermal estradiol Estraderm Cost 25ug patch ($41.88) 100ug patch ($48.27) 30 days supply
27 Transdermal estradiol Estradot Cost 25ug $34.88/bx of ug $34.93/bx of 8 50ug $36.57/bx 75ug $38.20/bx 100ug $39.73/bx 8 30 days supply
28 Transdermal estrogens Climara Osclim
29 Transdermal estrogens Files JA et al. Mayo Clin Proc 2011;86:673
30 Estring estradiol-17β indicated for the postmenopausal urogenital complaints due to estrogen deficiency drug reservoir of 2 mg estradiol releases 7.5 µg/24 hours over 90 days Cost ODB benefit
31 Vagifem 25ug or 10ug vaginal tablet with applicator ODB benefit
32 FDA approved vaginal estradiol Estring Ring 7.5ug/d q 90days Femring Ring 0.05 or 0.1mg q 90days Vagifem Tablet 10ug 1/d x 1 wk then 2-3x/wk Estrace cream 0.1mg/g Maintenance 1g 2-3x/wk
33 Human estrogens Hormone Human Estrone E % Estradiol E % Estriol E %
34 Compounded estrogen Original Tri-Est (2.5 mg) Estrone (10%) 0.25 mg Estradiol (10%) 0.25 mg Estriol (80%)2.0 mg Original Bi-Est (2.5 mg) Estradiol (20%) 0.5 mg Estriol (80%) 2.0 mg
35
36 C.E.S. Premarin or generic conjugated estrogens Tablets 0.3 mg, mg, 0.9 mg, 1.25 mg Cost ODB benefit
37 Human estrogens Hormone Human C.E.S - Premarin Estrone E % 75-80% Estradiol E % 5-15% Estriol E % Equilin 6-15%
38 Ethinyl estradiol Estrogen-like component in the OCP Physiologic replacement 0.05 mg OCP doses mg
39 Ethinyl estradiol vs 17B estradiol Adverse effect on hepatic protein synthesis induction and hemostatic parameters vs. 17-B estradiol Increased D-dimer, prothrombin, fibrinogen, mean APC sensitivity ratio Klipping C et al. Drugs in R&D 2011;11:159 Helgason S. Acta Obstet Gynecol Scand Suppl 1982; 107: 1-29 Lindberg UB et al. Thromb Haemost 1989;61:65 Mashchak CA et al. Am J Obstet Gynecol 1982;144:511 Wiegratz I et al. Contraception 2004;70:97
40
41 Estrogen equivalent effects Conjugated Estrogens Tri-Est or BiEst Estriol Estradiol Estradiol transdermal Estropipate (Ogen) Ethynil estradiol 0.625mg 2.5 mg 5 mg 1 mg 0.05 mg/24 hrs 0.75 mg 0.05 mg
42 Outline Hormones and the Menstrual cycle Ovarian hormone replacement Estrogens Progesterone Indications for replacement Cases
43 Progesterone
44 Prometrium micronized progesterone 100 mg. Nonmedicinal ingredients arachis (peanut) oil Dose 300mg PV or PO hs x 10d/month = luteal levels Cost bottle of 100 $52.75 price includes markup and $10.99 dispensing fee
45 Crinone g CRINONE 8% Vaginal Gel 90 mg progesterone intravaginally once or twice daily Cost Boxes of 18 $ price includes markup and $10.99 dispensing fee
46 Endometrin 100 mg progesteron effervescent vaginal tablets packed individually in a sealed foil pouch + applicator Cost Cartons packed with 21 vaginal tablets $ price includes markup and $10.99 dispensing fee
47 Progesterone Compounded Vaginal suppositories Transdermal Transbuccal troche Cost Suppositories 200mg $28.68/12 + dispensing fee
48 Cytex Progesterone Injection USP Dose 100mg CD 17, 21, mg 2/week pregnancy Cost 10 ml vial (50mg/ml) $80.29 price includes markup and $10.99 dispensing fee
49 Provera medroxyprogesterone acetate Progestin Cost 5mg $16.96/30 tabs 10mg $19.00/30 tabs price includes markup and $10.99 dispensing fee ODB benefit
50 Progestin equivalent effects Progesterone MPA mg 10mg
51 Progesterone vs. MPA Indistinguishable effects on endometrium Different effects on: Breast tissue proliferation Estrogen receptors Lipids Insulin resistance Vascular endothelium Hermsmeyer, RK Nature Clinical Practice Cardiovascular Medicine 2008;5:
52 Symptomatic efficacy for HRT Postmenopausal patients on HRT (4 studies) P4 vs. MPA resulted in: Greater satisfaction Fewer side effects Improved quality of life Hermsmeyer, RK Nature Clinical Practice Cardiovascular Medicine 2008;5:
53 Symptomatic efficacy for HRT P4 vs. MPA resulted in a decrease of: 30% sleep problems 50% anxiety 60% depression 30% somatic symptoms 25% menstrual bleeding 40% cognitive difficulties 30% sexual dysfunction 65% overall preference for P4 vs. MPA Fitzpatrick LA et al. J Womens Health Gend Based Med 2000;9:381
54 Symptomatic efficacy for HRT RCT MPA (vs. P4) resulted in: Increased vaginal bleeding p=0.003 Increased breast tenderness p=0.02 Trend for increased hot flashes PEPI trial 875 women CEE + MPA vs. P4 P4 fewer episodes of excessive bleeding No difference in symptomatic relief Cussings JA et al. Menopause 2002;9:253 Greendale GA et al. Obstet Gynecol 1989;92:982
55 Breast tissue effects Synthetic progestogens: Anti-apoptotic effects Increase estrogen-stimulated breast cell mitosis and proliferation Bind to estrogen receptors in breast tissue (not in endometrial tissue) resulting in estrogenic effects Increase conversion of weaker to more potent estrogens Estrone sulphate to active estrone Holtorf K Postgrad Med 2009;121:1
56 Breast tissue effects Progesterone Inhibits estrogen-stimulated breast epithelial cells Anti-estrogenic activity in breast tissue Downregulates ER-1 Induces breast cancer cell apoptosis Diminishes breast cell mitotic activity Arrest human breast cancer cells in G1 Upregulates cyclin-depepdent kinase inhibitors Downregulates cyclin D1 Holtorf K Postgrad Med 2009;121:1
57 Breast tissue effects 3 subclasses of progesterone receptors PRA, PRB, PRC Ratio PRA:PRB 1:1 in normal tissue Altered ratio in breast cancer cells Progestins alter normal ratio P4 no effect Holtorf K Postgrad Med 2009;121:1
58 Breast cancer risk with MPA Women s Health Initiative CES + MPA Breast cancer 1.26 (95% CI ) Nurses Health Study Addition of progestin to Estrogen 67% increase risk of breast cancer (95% CI ) Holtorf K Postgrad Med 2009;121:1
59 Breast cancer risk with Progesterone E3N-EPIC cohort - 80,000 women compared with women with no HRT Estrogen only 1.29 (p=0.73) E + synthetic progestin 1.69 (p=0.01) E + progesterone 0.9 (p=0.001) Fournier A et al. Int J Cancer 2005;114:448 Fournier A et al. Breast Cancer Res Treat 2008;107:103
60
61 Progesterone deficiency Prospective cohort 1083 infertile women Followed for years In women with low progesterone levels (vs. high) Premenopausal breast cancer risk 5.4x higher (95% CI ) Death from cancer 10x higher (95%CI ) Cowen LD et al. Am J Epidemiol 1981;114:
62 Progesterone deficiency Prospective cohort 5963 women Luteal progesterone levels compared with subsequent risk of breast cancer P4 inversely associated with breast ca risk Highest vs. lowest tertile RR=0.40, 95%CI , p=0.077 In women with normal menses (accurate timing) RR=0.12, 95%CI , p=0.005 Micheli A et al. Int J Cancer 2004;112:312
63 Progesterone deficiency Nestled case-control study T3 progesterone levels ( ) and risk of breast cancer ( ) 194 cases vs. 374 controls P4 inversely associated with breast ca risk Highest (> ng/ml) vs. lowest (< ng/ml) quartile RR=0.49, 95%CI , p for trend=0.08 In women dx with cancer at or before age 50 RR=0.3, 95%CI , p=0.04 Peck JD et al. Cancer Epidemiol Biomarkers Prev 2002;11:361
64 Cardiovascular risk HDL effect MPA consistently reduces HDL Progesterone maintains or augments estrogen s positive lipid and HDL effects Vascular cell adhesion molecule-1 (VCAM-1) Expressed early in atherosclerotic process Progesterone inhibits VCAM-1 No effect with MPA Holtorf K Postgrad Med 2009;121:1
65 Hermsmeyer, RK Nature Clinical Practice Cardiovascular Medicine 2008;5:
66 Synthetic vs. natural progesterone Hermsmeyer, RK Nature Clinical Practice Cardiovascular Medicine 2008;5:
67 Progestins in OCP chemical derivatives of testosterone (known as 19- nortestosterone derivatives) estrane family first generation progestins Norethindrone other progestins that metabolize to norethindrone (norethindrone acetate and ethynodiol diacetate) gonane family second generation progestins, which have varying degrees of androgenic and estrogenic activities levonorgestrel norgestrel
68 Progestins in OCP Third generation progestins The least androgenic effects Desogestrel Norgestimate. Drospirenone newest (4th) generation derived from 17a-spirolactone Third (and forth) generation progestins highly selective minimal androgenic properties may carry a higher risk of blood clots
69 Outline Hormones and the Menstrual cycle Ovarian hormone replacement Estrogens Progesterone Indications for replacement Cases
70 Indications for OHRT Premature ovarian failure Turner s syndrome Peri/post-menopausal symptoms Subfertility Holtorf K Postgraduate Medicine 2009;121:1-13
71 Indications for progesterone Anovulation PCOS Dysfunctional uterine bleeding PMS Luteal phase defects Recurrent miscarriage Peri/post-menopausal symptoms DiRenzo GC Curr Opin Obstet Gynecol 2005;17:598 Holtorf K Postgraduate Medicine 2009;121:1-13
72 Outline Hormones and the Menstrual cycle Ovarian hormone replacement Estrogens Progesterone Indications for replacement Cases
73 Case 1
74 Case 1 32F amenorrhea x 6 months HCG negative Negative progesterone withdrawal
75 Case 1 32F amenorrhea x 6 months HCG negative Negative progesterone withdrawal FSH 76 IU/L LH 46 IU/L Estradiol <18
76 Case 1 32F amenorrhea x 6 months HCG negative Negative progesterone withdrawal FSH 76 IU/L LH 46 IU/L Estradiol <18 No vasomotor symptoms Mild dyspareunia due to vaginal dryness
77 Estrogen equivalent effects Conjugated Estrogens Tri-Est or BiEst Estriol Estradiol Estradiol transdermal Estropipate (Ogen) Ethynil estradiol 0.625mg 2.5 mg 5 mg 1 mg 0.05 mg/24 hrs 0.75 mg 0.05 mg
78 Estrogen Transdermal estradiol Start 25-50ug Calendar day 1-27 Avoid estrogen dominant symptoms Breast tenderness Headaches Titrate based on Symptoms Target estradiol level 200 pmol/l for women <50
79 Progestin equivalent effects Progesterone MPA mg 10mg
80 Progesterone Prometrium 200mg PV/PO hs 100mg/25ug estradiol Calendar day Prime uterus for one month with estradiol only then add progesterone
81 Progesterone Titrate based on Withdrawal bleeding Symptoms Target progesterone level 15 nmol/l per 100 mg Eg. On 200mg around 30 nmol/l
82 Questions What if she was 45? When would you stop hormones and how? What is she didn t want to cycle? What if she is ODSB? What if she wants to conceive?
83 Case 2 - PCOS
84 Case 2 - PCOS 28F PCOS Anovulatory bleeding Every 6-10 weeks Acne No hirsuitism Impaired glucose tolerance Trying to conceive
85 Case 2 - PCOS Withdrawal bleeding Provera 10mg PO x 10 d/m Prometrium 300mg PV or PO HS x 10 d/m Progesterone vaginal suppositories 300mg PV
86 Cervical mucous changes Follicular phase Luteal phase Basal Body Temperature
87 Case 3 Perimenopausal DUB
88 Case 3 Perimenopausal DUB 47F G3P1 Dysfunctional uterine bleeding Menometrorrhagia day cycles Up to 6 weeks of continuous bleeding very light SHG no polyps or fibroids No coagulopathy Advised to get hysterectomy or endometrial ablation
89 Age 36 Age 47 Estradiol Progesterone
90 Cooperative progesterone Rx Progesterone mg PV hs for 10 days Progesterone 200 mg IM every 2 days until bleeding stops then monthly progesterone Progesterone 100 mg IM CD 17, 20, 23 Progesterone 300 mg PV CD 17-26
91 Outline Hormones and the Menstrual cycle Ovarian hormone replacement Estrogens Progesterone Indications for replacement Cases
Menopausal Symptoms. Hormone Therapy Products Available in Canada for the Treatment of. Physician Desk Reference - 3rd Edition
Hormone Therapy Products Available in Canada for the Treatment of Menopausal Symptoms Physician Desk Reference - 3rd Edition A clinical resource provided to you by: The Society of Obstetricians and Gynaecologists
More informationAppendix: Reference Table of HT Brand Names
Appendix: Reference Table of HT Brand Names This is a full reference table in alphabetical order, of Brand Name drugs used in HT. It is the basis for prescription advice throughout this handbook. Drug
More informationDeciding whether or not to use Hormone Therapy (HT) is a big decision and should be
Deciding whether or not to use Hormone Therapy (HT) is a big decision and should be made with input from your healthcare provider. After the decision has been made to take HT, many women don t realize
More informationMenopause. Medicines To Help You
Medicines To Help You Menopause Use this guide to help you talk to your doctor, pharmacist, or nurse about your hormone medicines. The guide lists all of the FDA-approved products now available to treat
More informationHormone Products for Postmenopausal Use in the United States and Canada
Hormone Products for Postmenopausal Use in the United States and Canada Copyright The North American Menopause Society October 25, 2011 Table 1. Oral ET products for postmenopausal use in the United States
More informationEstrogens and progestogens
Estrogens and progestogens Estradiol and Progesterone hormones produced by the gonads are necessary for: conception embryonic maturation development of primary and secondary sexual characteristics at puberty.
More informationBreast Cancer Risk in Patients Using Hormonal Contraception
Breast Cancer Risk in Patients Using Hormonal Contraception Bradley L. Smith, Pharm.D. Smith.bradley1@mayo.edu Pharmacy Ground Rounds Mayo Clinic Rochester April 3 rd, 2018 2017 MFMER slide-1 Presentation
More informationFOUNDATIONAL PRINCIPLES OF BIO-IDENTICAL HORMONE REPLACEMENT THERAPY: THE WHO, WHAT, WHERE, WHEN, AND WHYS. Dr. Kristy A. Prouse, MD, FRCSC (OB/Gyn)
1 FOUNDATIONAL PRINCIPLES OF BIO-IDENTICAL HORMONE REPLACEMENT THERAPY: THE WHO, WHAT, WHERE, WHEN, AND WHYS Dr. Kristy A. Prouse, MD, FRCSC (OB/Gyn) 2 HOUSEKEEPING Cell Phones Download the Slides Questions
More informationBioIdentical Hormone Replacement Therapy for Women
BioIdentical Hormone Replacement Therapy for Women Bio-Identical Hormones are manufactured hormone products from soy or yam. They are changed in a laboratory so that the hormones produced are identical
More informationLearning Objectives. Peri menopause. Menopause Overview. Recommendation grading categories
Learning Objectives Identify common symptoms of the menopause transition Understand the risks and benefits of hormone replacement therapy (HRT) Be able to choose an appropriate hormone replacement regimen
More informationEstrogens & Antiestrogens
Estrogens & Antiestrogens Menstrual cycle... Changes and hormonal events Natural estrogens: Estadiol >> Estrone > Estriol Ineffective orally Synthesis: From cholesterol ; role of aromatase enzyme in converting
More informationBioidentical Hormones: Just the Facts
Bioidentical Hormones: Just the Facts Melissa McNeil, MD, MPH Professor of Medicine and Obstetrics, Gynecology and Reproductive Sciences Chief, Section of Women s Health University of Pittsburgh Disclosures!
More informationAbnormal Uterine Bleeding Case Studies
Case Study 1 Abnormal Uterine Bleeding Case Studies Abigail, a 24 year old female, presents to your office complaining that her menstrual cycles have become a problem. They are now lasting 6 7 days instead
More informationBioidentical hormone therapy: Clarifying the misconceptions
CURRENT DRUG THERAPY CME CREDIT EDUCATIONAL OBJECTIVE: Readers will discuss the risks and benefits of hormone therapy with their patients LYNN PATTIMAKIEL, MD, NCMP Department of Internal Medicine, Center
More informationCASE 41. What is the pathophysiologic cause of her amenorrhea? Which cells in the ovary secrete estrogen?
CASE 41 A 19-year-old woman presents to her gynecologist with complaints of not having had a period for 6 months. She reports having normal periods since menarche at age 12. She denies sexual activity,
More informationPCOS and Obesity DUB is better treated by OCPs
PCOS and Obesity DUB is better treated by OCPs Dr. Ritu Joshi Senior consultant Fortis escorts Hospital, Jaipur Chairperson Family welfare com. FOGSI (20092012) Vice President FOGSI 2014 Introduction One
More information11/11/2015. Calm Your Hormones! OR EVERYTHING YOU SHOULD KNOW ABOUT HORMONE THERAPIES
Jill Earl CNM,CRNP Calm Your Hormones! OR EVERYTHING YOU SHOULD KNOW ABOUT HORMONE THERAPIES Hormone Production &Utilization LITTLE PACKAGES WITH A BIG IMPACT Key Components of Overall Health Chemical
More informationHORMONES AND YOUR HEALTH Charlie Tucker Pharm. D
HORMONES AND YOUR HEALTH Charlie Tucker Pharm. D All of the hormones in your body are designed to work together. This is God s plan. Therefore, if one is altered, or deficient, it will affect the actions
More informationFemale Sexual Hormones Indications and Therapy
Female Sexual Hormones Indications and Therapy In puberty, a woman has about 400,000 ovules, at the age of 40-44 years about 17,000 only. On average, each grown-up woman (still having ovulation) loses
More informationTherapeutic Cohort Results
Patient: SAMPLE PATIENT DOB: Sex: MRN: Menopause Plus - Salivary Profile Therapeutic Cohort Results Hormone Average Result QUINTILE DISTRIBUTION 1st 2nd 3rd 4th 5th Therapeutic Range* Estradiol (E2) 8.7
More informationDisclosures. Objec7ves 9/9/15. What Exactly are bio- iden7cal hormones and what should I tell my pa7ents? Christy Blanco, DNP, RN, WHNP- BC.
What Exactly are bio- iden7cal hormones and what should I tell my pa7ents? Christy Blanco, DNP, RN, WHNP- BC Disclosures None Objec7ves Discuss terminology of bio- iden7cal, synthe7c and natural hormones.
More informationPERIMENOPAUSE. Objectives. Disclosure. The Perimenopause Perimenopause Menopause. Definitions of Menopausal Transition: STRAW.
PERIMENOPAUSE Patricia J. Sulak, MD Founder, Living WELL Aware LLC Author, Should I Fire My Doctor? Author, Living WELL Aware: Eleven Essential Elements to Health and Happiness Endowed Professor Texas
More informationUPDATE: Women s Health Issues
UPDATE: Women s Health Issues Renee B. Alexis, MD, MBA, MPH, FACOG Associate Professor Department of OBGYN Kiran C. Patel College of Osteopathic Medicine Disclosure of Conflicts of Interest I have no financial
More informationA Practitioner s Toolkit for the Management of the Menopause
Medicine, Nursing and Health Sciences A Practitioner s Toolkit for the Management of the Menopause Developed by the Women s Health Research Program School of Public Health and Preventive Medicine Monash
More informationTherapeutic Cohort Results
Patient: JANE DOE DOB: December 31, 1968 Sex: F MRN: Order Number: Completed: February 26, 2016 Received: February 26, 2016 Collected: February 26, 2016 One Day Hormone Check - Salivary Profile Therapeutic
More informationWomen s Health: Managing Menopause. Jane S. Sillman, MD Assistant Professor of Medicine Harvard Medical School
Women s Health: Managing Menopause Jane S. Sillman, MD Assistant Professor of Medicine Harvard Medical School Disclosures I have no conflicts of interest. Learning Objectives 1. Apply strategies to help
More informationTherapeutic Cohort Results
Patient: PAGE LOVE DOB: January 11, 1983 Sex: F MRN: 1232704193 Order Number: J9020008 Completed: July 08, 2016 Received: July 02, 2016 Collected: July 01, 2016 Aum Healing Center Sarika Arora MD 332 Newbury
More informationReproductive System. Testes. Accessory reproductive organs. gametogenesis hormones. Reproductive tract & Glands
Reproductive System Testes gametogenesis hormones Accessory reproductive organs Reproductive tract & Glands transport gametes provide nourishment for gametes Hormonal regulation in men Hypothalamus - puberty
More informationPOTION OR POISON? MEDICAL TREATMENT ALTERNATIVES TO THE PILL. Lester Ruppersberger, D.O., FACOOG,CNFPI NFP only Gynecologist
POTION OR POISON? MEDICAL TREATMENT ALTERNATIVES TO THE PILL Lester Ruppersberger, D.O., FACOOG,CNFPI NFP only Gynecologist THE PILL Released to US market in 1960 10-15 x dose of hormones in HRT Over 10-14
More informationOrals,Transdermals, and Other Estrogens in the Perimenopause
Orals,Transdermals, and Other Estrogens in the Perimenopause Cases Denise Black, MD, FRCSC Assistant Professor, Obstetrics, Gynecology and Reproductive Sciences University of Manitoba 6/4/18 197 Faculty/Presenter
More information2017 Position Statement of Hormone Therapy of NAMS: overview SHELAGH LARSON, MS, RNC WHNP, NCMP ACCLAIM, JPS HEALTH NETWORK
2017 Position Statement of Hormone Therapy of NAMS: overview SHELAGH LARSON, MS, RNC WHNP, NCMP ACCLAIM, JPS HEALTH NETWORK WHI the only large, long-term RCT of HT in women aged 50 to 79 years, Drug trail
More informationCurrent Topics in Hormone Replacement Therapy
Current Topics in Hormone Replacement Therapy Corey R. Babb, D.O., FACOOG, IF, NCMP Clinical Assistant Professor of Obstetrics and Gynecology Director of the Oklahoma State University Center for Women
More informationFemale sex steroids and contraceptives agents
Female sex steroids and contraceptives agents Female Sex Hormones Sex hormones produced by the gonads are necessary for conception, embryonic maturation, and development of primary and secondary sexual
More informationMenopause & HRT. Rosie & Alex. Image:
Menopause & HRT Rosie & Alex Image: http://www.keepcalm-o-matic.co.uk/ Menopause The permanent cessation of menstruation for 12 months When does it happen? Average age 51 Image: Nature Medicine - 12, 612-613
More informationEndocrinology of the Female Reproductive Axis
Endocrinology of the Female Reproductive Axis girlontheriver.com Geralyn Lambert-Messerlian, PhD, FACB Professor Women and Infants Hospital Alpert Medical School at Brown University Women & Infants BROWN
More informationReproductive Health and Pituitary Disease
Reproductive Health and Pituitary Disease Janet F. McLaren, MD Assistant Professor Division of Reproductive Endocrinology and Infertility Department of Obstetrics and Gynecology jmclaren@uabmc.edu Objectives
More information22/09/2014. Menopause Management. Menopause. Menopause symptoms
Menopause Management Dr Sonia Davison Jean Hailes for Women s Health Menopause Time of last menstrual period - average age 51 Premature Menopause: occurs before age 40 Perimenopause (menopause transition):
More informationMenopausal Management: What Has Changed?
Menopausal Management: What Has Changed? Julia V. Johnson, M.D. Professor and Chair, OB/GYN University of Massachusetts Medical School UMass Memorial Medical Center Conflicts of Interest None Learning
More informationWhat's New in Menopause Management
Annual Review of Family Medicine December 10, 2015 San Francisco, CA What's New in Menopause Management Michael Policar, MD, MPH Clinical Professor of Ob, Gyn, and Repro Sciences UCSF School of Medicine
More informationTURNING DOWN THE HEAT ON MENOPAUSE. Erika Schwartz, M.D.
TURNING DOWN THE HEAT ON MENOPAUSE Erika Schwartz, M.D. www.drerika.com www.bhionline.org U.S. Census Bureau, 2004 US Female Population (000 s) 100000 90000 80000 70000 60000 50000 40000 30000 20000 10000
More information8605 SW Creekside Place Beaverton, OR Phone: Fax: Samples Collected. Samples Received 06/21/2017
TEST RESULTS Ordering Provider: Getuwell Clinic Patient Name: Patient Phone Number: 555 555 5555 Gender Female DOB 6/9/1978 (39 yrs) Menses Status Pre-Menopausal 8605 SW Creekside Place Beaverton, OR 97008
More informationSAMPLE REPORT. Order Number: PATIENT. Age: 40 Sex: F MRN:
Patient: Age: 40 Sex: F MRN: SAMPLE PATIENT Order Number: Completed: Received: Collected: SAMPLE REPORT Progesterone ng/ml 0.34 0.95 21.00 DHEA-S mcg/dl Testosterone ng/ml 48 35 0.10 0.54 0.80 430 Sex
More informationJim Paoletti BS Pharmacy, FAARM, FIACP, Director of Education, P2P
presents Converting Patients from Conventional Pioneering Technologies For to Bioidentical Lifestyle Based Medicine Hormone Therapy with Jim Paoletti BS Pharmacy, FAARM, FIACP, Director of Education, P2P
More informationDrug Class Review on Hormone Therapy for Postmenopausal Women or Women in the Menopausal Transition Stage
Drug Class Review on Hormone Therapy for Postmenopausal Women or Women in the Menopausal Transition Stage Final Report Update 3 October 2007 Original Report Date: February 2003 Update 1 Report Date: November
More information2016. All Rights Reserved. 1
Pamela W. Smith, M.D., MPH, MS Copyright 2016 The suggested dosages are for educational purposes only. They are suggestions for patients with normal renal and hepatic function. They are based upon my research
More informationReproductive physiology
Reproductive physiology Sex hormones: Androgens Estrogens Gestagens Learning objectives 86 (also 90) Sex Genetic sex Gonadal sex Phenotypic sex XY - XX chromosomes testes - ovaries external features Tha
More informationHRT in Perimenopausal Women. Dr. Rubina Yasmin Asst. Prof. Medicine Dhaka Dental College
HRT in Perimenopausal Women Dr. Rubina Yasmin Asst. Prof. Medicine Dhaka Dental College 1 This is the Change But the CHANGE is not a disease 2 Introduction With a marked increase in longevity, women now
More informationNavigating the Change: Leading Patients Through Menopause
4:30pm - 5:30pm: Breakout 5 - Women s Health Option A: Navigating the Change: Leading Patients Through Menopause ACPE UAN 0107-0000-10-025-L01-P 0.1 CEU/1.0 Hr. Activity Type: Application-Based Program
More informationFemale Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF
Female Reproductive Physiology Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF REFERENCE Lew, R, Natural History of ovarian function including assessment of ovarian reserve
More informationIs generic progesterone the same as prometrium
Is generic progesterone the same as prometrium The Borg System is 100 % Is generic progesterone the same as prometrium The progestins in hormonal birth control are not progesterone. They have different
More informationIndian Menopause Society-Goals
Indian Menopause Society-Goals Forum for discussion on all aspects of Menopause and Hormone Therapy To promote Public Awareness Multi disciplinary body Research Promote comprehensive health care for Adult
More informationPearls for Menopause Management: I m ready: now what?
Pearls for Menopause Management: I m ready: now what? Friday November 13, 2015 Susan Goldstein MD CCFP FCFP NCMP Assistant Professor Department of Family and Community Medicine University of Toronto Menarche
More informationProgesterone, A Central Role in Hormone Balance and Cycle Control Today s Ignorance of Hormonal Importance:
G eorgia H orm ones, P.C. R obert P. G oldm an, M D 3400-A O ld M ilton P kw k y, Suite 360, A lpharetta G A 30005 770-475 475-0077 w w w.g eorgiah orm ones.com 2009-05-18 Progesterone, A Central Role
More informationHormone. Free Androgen Index. 2-Hydroxyestrone. Reference Range. Hormone. Estrone Ratio. Free Androgen Index
Hormonal Health PATIENT: Sample Report TEST REF: TST-12345 Hormonal Health 0.61 0.30-1.13 ng/ml DHEA-S 91 35-430 mcg/dl tient: SAMPLE TIENT e: x: N: Sex Binding Globulin 80 18-114 nmol/l Testosterone 0.34
More informationOVERVIEW OF MENOPAUSE
OVERVIEW OF MENOPAUSE Nicole Budrys, MD, MPH Reproductive Endocrinology Michigan Center for Fertility and Women s Health Presented at SEMCME March 13,2019 Objectives Define menopause Etiology of menopause
More informationTopics. Periods Menopause & HRT Contraception Vulva problems
Girls stuff Topics Periods Menopause & HRT Contraception Vulva problems Menorrhagia Excessive menstrual loss occurring with regular or irregular cycles Ovulatory Anovulatory Usual blood loss 30-40ml per
More informationHORMONE REPLACEMENT THERAPY-UPDATE KHALED SAKHEL, MD FACOG FACS FAIUM ASSOCIATE PROFESSOR EASTERN VIRGINIA MEDICAL SCHOOL
HORMONE REPLACEMENT THERAPY-UPDATE KHALED SAKHEL, MD FACOG FACS FAIUM ASSOCIATE PROFESSOR EASTERN VIRGINIA MEDICAL SCHOOL INTRODUCTION NORMAL WOMEN HAVE MENOPAUSE AT A MEAN AGE OF 51 YEARS, WITH 95 PERCENT
More informationPolycystic Ovary Syndrome HEATHER BURKS, MD OU PHYSICIANS REPRODUCTIVE MEDICINE SEPTEMBER 21, 2018
Polycystic Ovary Syndrome HEATHER BURKS, MD OU PHYSICIANS REPRODUCTIVE MEDICINE SEPTEMBER 21, 2018 Learning Objectives At the conclusion of this lecture, learners should: 1) Know the various diagnostic
More informationSexual dysfunction of chronic kidney disease. Razieh salehian.md psychiatrist
Sexual dysfunction of chronic kidney disease Razieh salehian.md psychiatrist Disturbances in sexual function are a common feature of chronic renal failure. Sexual dysfunction is inversely associated with
More informationOB/GYN Update: Menopausal Management What Does The Evidence Show? Rebecca Levy-Gantt D.O. PremierObGyn Napa Inc.
OB/GYN Update: Menopausal Management What Does The Evidence Show? Rebecca Levy-Gantt D.O. PremierObGyn Napa Inc. Napa, California IMPORTANT SAFETY INFORMATION ABOUT EVAMIST: WARNING: ENDOMETRIAL CANCER,
More informationHormonal Control of Human Reproduction
Hormonal Control of Human Reproduction Bởi: OpenStaxCollege The human male and female reproductive cycles are controlled by the interaction of hormones from the hypothalamus and anterior pituitary with
More informationEstrogen (conjugated estrogens & ethinyl estradiol) Addition to the List
Estrogen (conjugated estrogens & ethinyl estradiol) Addition to the List Note: Commonly prescribed medication. Literature question Is estrogen effective and safe? Are conjugated estrogens effective and
More informationHormone Balance - Female Report SAMPLE. result graph based on Luteal Phase. result graph based on Luteal Phase
Patient Name: Patient DOB: Gender: Physician: Test Hormone Balance - Female Report SAMPLE Grote, Mary Jane Batch Number: B6437 2/16/1954 Accession Number: N52281 F Date Received: 2/3/2015 Any Lab Test
More information5. Summary of Data Reported and Evaluation
168 IARC MONOGRAPHS VOLUME 91 5. Summary of Data Reported and Evaluation 5.1 Exposure data The first oral hormonal contraceptives that were found to inhibit both ovulation and implantation were developed
More informationIn the aftermath of the unexpected adverse results of the
Bioidentical Hormones: An Evidence-Based Review for Primary Care Providers Eileen Conaway, DO Context: Since 2002, when the US Food and Drug Administration (FDA) placed a black box warning on women s hormone
More informationBioidentical Hormone Preparations - History of Development
Bioidentical Hormone Preparations - History of Development The use of the terminology BIOIDENTICAL HORMONE therapy has aroused much controversy and heated debate over the past 20 years, often with much
More informationCase Questions. Polycystic Ovarian Syndrome: Treatment Goals and Options. Differential Diagnosis of Hyperandrogenic Anovulation
Polycystic Ovarian Syndrome: Treatment Goals and Options Marc Cornier, MD Division of Endocrinology, Metabolism and Diabetes Colorado Center for Health and Wellness University of Colorado School of Medicine
More informationBiology of Reproduction- Zool 346 Exam 2
Biology of Reproduction- Zool 346 Exam 2 ANSWER ALL THE QUESTIONS ON THE ANSWER SHEET. THE ANSWER ON THE ANSWER SHEET IS YOUR OFFICIAL ANSWER. Some critical words are boldfaced. This exam is 7 pages long.
More informationFrequency of menses. Duration of menses 3 days to 7 days. Flow/amount of menses Average blood loss with menstruation is 60-80cc.
Frequency of menses 24 days (0.5%) to 35 days (0.9%) Age 25, 40% are between 25 and 28 days Age 25-35, 60% are between 25 and 28 days Teens and women over 40 s cycles may be longer apart Duration of menses
More informationPost-menopausal hormone replacement therapy. Evan Klass, MD May 17, 2018
Post-menopausal hormone replacement therapy Evan Klass, MD May 17, 2018 Are we really still talking about this? Are we really still talking about this? 1960-1975- estrogen prescriptions doubled. Pharma
More informationMenopause management NICE Implementation
Menopause management NICE Implementation Dr Paula Briggs Consultant in Sexual & Reproductive Health Southport and Ormskirk NHS Hospital Trust Why a NICE guideline (NG 23) Media reports about HRT have not
More informationpresents with Ken Sekine, MD
presents Pioneering Technologies For Pellet Hormone Therapy Lifestyle Based Medicine A Primer for Clinicians with Ken Sekine, MD Dr. Sekine is a board certified OB-GYN who has been in private practice
More informationManagement of Perimenopausal symptoms
Management of Perimenopausal symptoms Serge Rozenberg CHU St Pierre Université libre de Bruxelles Belgium serge_rozenberg@stpierre-bru.be serge.rozenberg@skynet.be Conflict of interest & Disclosure Conflicts
More informationWomen s Issues in Epilepsy. Esther Bui, Epilepsy Fellow MD, FRCPC
Women s Issues in Epilepsy Esther Bui, Epilepsy Fellow MD, FRCPC How are women different? Different habitus Different metabolism Different co-morbidities Different psychosocial stigma Different hormonal
More information1/11/2017. Disclosure Statement. Describe the most common medical issues associated with peri-menopause and menopause. Case study:
The Pharmacological Management of Peri-Menopause and Menopause Debora Bear, FNP, MSN, MPH University Of New Mexico Hospital Hormones and other Treatments Gwen Iffil, Stepmber 29, 19 to vember 14, 2016
More informationMENOPAUSE. I have no disclosures 10/11/18 OBJECTIVES WHAT S NEW? WHAT S SAFE?
MENOPAUSE WHAT S NEW? WHAT S SAFE? I have no disclosures Sara Whetstone, MD, MHS OBJECTIVES To describe risks of HT by age and menopause onset To recommend specific HT regimen for women who undergo early
More informationPolycystic Ovary Syndrome
Polycystic Ovary Syndrome Definition: the diagnostic criteria Evidence of hyperandrogenism, biochemical &/or clinical (hirsutism, acne & male pattern baldness). Ovulatory dysfunction; amenorrhoea; oligomenorrhoea
More informationConflicts 10/5/2016. Abnormal Uterine Bleeding. Objectives Review diagnosis and updated nomenclature. Management options for acute and chronic AUB.
Abnormal Uterine Bleeding Barbara L. Keller, MD JD Naval Hospital Oak Harbor OB/GYN Physician Conflicts I have no conflicts or financial interests to disclose. Objectives Review diagnosis and updated nomenclature.
More informationOne Day Hormone Check
One Day Hormone Check DOB: Sex: F MRN: Order Number: Completed: Received: Collected: Salivary Hormone Results Estradiol pmol/l >3330.0 Testosterone pmol/l
More informationORILISSA (elagolix) oral tablet
ORILISSA (elagolix) oral tablet Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy Coverage
More informationTable I. Examples of Hormone and Tapering Regimens
Table I. Examples of Hormone and Tapering Regimens Severe AUB Heavy bleeding (soaking through 2 maxi pads an hour, 2 hours in a row) History of heavy menses Hemodynamically un (tachycardia, hypotensive,
More informationThe reproductive lifespan
The reproductive lifespan Reproductive potential Ovarian cycles Pregnancy Lactation Male Female Puberty Menopause Age Menstruation is an external indicator of ovarian events controlled by the hypothalamicpituitary
More informationPre-Post Reproductive years, The Change. Nayan Patel PharmD
Pre-Post Reproductive years, The Change Nayan Patel PharmD Dysmenorrhea: Definition Painful menstruation that prevents a woman from performing normal activities * Primary dysmenorrhea no readily identifiable
More informationOne Day Hormone Check
One Day Hormone Check Patient: EMILY TEST DOB: January 18, 1948 Sex: F MRN: 0000000004 Order Number: J5070009 Completed: March 07, 2014 Received: March 07, 2014 Collected: March 07, 2014 Alec Smart, ND
More informationEffects of TX-001HR on Uterine Bleeding Rates in Menopausal Women with Vasomotor Symptoms
Effects of TX-001HR on Uterine Bleeding Rates in Menopausal Women with Vasomotor Symptoms Photo (compulsory) Steven R Goldstein, MD 1 ; Ginger D Constantine, MD 2 ; David F Archer, MD 3 ; James H Pickar,
More informationOverview of Reproductive Endocrinology
Overview of Reproductive Endocrinology I have no conflicts of interest to report. Maria Yialamas, MD Female Hypothalamic--Gonadal Axis 15 4 Hormone Secretion in the Normal Menstrual Cycle LH FSH E2, Progesterone,
More informationWEIGHT GAIN DURING MENOPAUSE EMERGING RESEARCH
MENOPAUSE WHEN DOES IT OCCUR? The cessation of the menstrual cycle for one year. WEIGHT GAIN DURING MENOPAUSE EMERGING RESEARCH Jan Schroeder, Ph.D. Chair of The Department of Kinesiology California State
More informationMenopausal Symptoms The Who: Hot flashes are reported by as many as 75% of perimenopausal women in the U.S.
Menopausal Hormone Therapy: The Who, What, Where, When and Why Laurie Birkholz, MD, NCMP Knowledge of Clinical Trials Regarding Hormone Therapy and Likelihood of Prescribing Hormone Objective: The aim
More informationMenopause & HRT. Matt McKenna Elliot Davis
Menopause & HRT Matt McKenna Elliot Davis Menopause Before age 40: Premature Menopause After 12 months clinical diagnosis made Depletion of Ovarian Follicles Oestrogen Progesterone LH FSH Spontaneous Amemorrhoea
More informationTest Results SB Samples Arrived: 01/15/2014 Samples Collected: Saliva: 01/11/14 07:14 Date Closed: 01/18/2014
Test Results 8605 SW Creekside Place Beaverton, OR 97008 Phone: 503-466-2445 Fax: 503-466-1636 info@zrtlab.com www.zrtlab.com 2014 01 15 001 SB Samples Arrived: 01/15/2014 Samples Collected: Saliva: 01/11/14
More informationA Tale of Three Hormones: hcg, Progesterone and AMH
A Tale of Three Hormones: hcg, Progesterone and AMH Download the Ferring AR ipad/iphone app from the Apple Store: http://bit.ly/1okk74m Human Ovarian Steroidogenesis and Gonadotrophin Stimulation Johan
More informationWhat s New in Menopause Management. Objectives
What s New in Menopause Management Leslee L. Subak, MD Professor of Obstetrics, Gynecology & Reproductive Science University of California, San Francisco Objectives Define the menopause transition Review
More informationDysfunctional Uterine Bleeding (DUB) OB/GYN Hospital of Fudan University Weiwei Feng, MD,Ph D Tel:
Dysfunctional Uterine Bleeding (DUB) OB/GYN Hospital of Fudan University Weiwei Feng, MD,Ph D Email: wfeng7347@aliyun.com Tel: 13918551061 2014-8-20 Contents DUB: definition, mechanism of normal menses,
More informationCommunity Gynaecology. Top Tips for GPs
Community Gynaecology Top Tips for GPs Top Tips for GPs Case Scenarios- common referral themes 6 topics What you can do in Primary Care to avoid or before referral. What we don t need to see Triage ensures
More informationCynthia Morris DO, FACOOG, FACOS Medical Director, Women s Wellness Center Fayette County Memorial Hospital
Cynthia Morris DO, FACOOG, FACOS Medical Director, Women s Wellness Center Fayette County Memorial Hospital Touchdown to CME Eighth District Academy of Osteopathic Medicine & Surgery October 8. 2017 Goals
More informationADRENOCORTICOTROPIN (ACTH) Hormone made by the pituitary gland that stimulates production of adrenal hormones.
ADRENAL GLANDS Produce several hormones including cortisol and DHEA. These glands take over at menopause to become the main source of all sex hormone production in the body. ADRENAL IMBALANCE Also known
More informationMenopause and HRT. John Smiddy and Alistair Ledsam
Menopause and HRT John Smiddy and Alistair Ledsam Menopause The cessation of menstruation Diagnosed retrospectively after 1 year of amenorrhoea Average age 51 in the UK Normal physiology - Menstruation
More informationManaging Menstrual Disorders
Managing Menstrual Disorders David G. Weismiller, MD, ScM, FAAFP Professor Department of Family Medicine The Brody School of Medicine at East Carolina University Greenville, North Carolina Learning Objectives
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Abdominal myomectomy in leiomyoma management, 77 Abnormal uterine bleeding (AUB) described, 103 105 normal menstrual bleeding vs., 104
More informationChapter 27 The Reproductive System. MDufilho
Chapter 27 The Reproductive System 1 Figure 27.19 Events of oogenesis. Before birth Meiotic events 2n Oogonium (stem cell) Mitosis Follicle development in ovary Follicle cells Oocyte 2n Primary oocyte
More information